Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / ADR
-
Shares outstanding
-
50.2M
-
Number of holders
-
45
-
Total 13F shares, excl. options
-
17.1M
-
Shares change
-
+653K
-
Total reported value, excl. options
-
$587M
-
Value change
-
+$22M
-
Number of buys
-
18
-
Number of sells
-
-20
-
Price
-
$34.24
Significant Holders of Immunocore Holdings plc - ADR (IMCR) as of Q4 2021
51 filings reported holding IMCR - Immunocore Holdings plc - ADR as of Q4 2021.
Immunocore Holdings plc - ADR (IMCR) has 45 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17.1M shares
of 50.2M outstanding shares and own 34.11% of the company stock.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (2.52M shares), Rock Springs Capital Management LP (2.47M shares), FMR LLC (2.12M shares), WELLINGTON MANAGEMENT GROUP LLP (1.41M shares), RTW INVESTMENTS, LP (1.25M shares), Avidity Partners Management LP (1.23M shares), GENERAL ATLANTIC, L.P. (950K shares), Bain Capital Public Equity Management II, LLC (712K shares), FIRST MANHATTAN CO (510K shares), and BlackRock Inc. (496K shares).
This table shows the top 45 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.